Kris Kemp

Aug 15, 2024 | mondaq.com | Meredith Collins |David Cox |Angela Humphreys |Kris Kemp

Although the U.S. healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. Dry powder held by U.S. private equity investors has reached an all-time high, and with capital on the sideline ready to deploy, pressure to get deals done is on the rise. With that backdrop, navigating the healthcare M&A landscape continues to be increasingly challenging, especially with an ever-evolving regulatory landscape.